Tailoring cognitive-behavioral therapy to treat anxiety comorbid with advanced cancer

Joseph A. Greer, Elyse R. Park, Holly G. Prigerson, Steven Safren

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Patients with advanced cancer often experience debilitating anxiety symptoms that interfere with quality of life and relate to worse medical outcomes. Although cognitive-behavioral therapy (CBT) is an empirically validated, first-line treatment for anxiety disorders, clinical trials of CBT for anxiety typically exclude patients with medical comorbidities in general, and those with terminal illnesses, such as advanced cancer, in particular. Moreover, CBT has generally targeted unrealistic fears and worries in otherwise healthy individuals with clinically significant anxiety symptoms. Consequently, traditional CBT does not sufficiently address the cognitive components of anxiety in patients with cancer, especially negative thought patterns that are rational but nonetheless intrusive and distressing, such as concerns about pain, disability, and death, as well as management of multiple stressors, changes in functional status, and burdensome medical treatments. In this article, we describe a treatment approach for tailoring CBT to the needs of this population. Three case examples of patients diagnosed with terminal lung cancer are presented to demonstrate the treatment methods along with outcome measures for anxiety and quality of life.

Original languageEnglish (US)
Pages (from-to)294-313
Number of pages20
JournalJournal of Cognitive Psychotherapy
Volume24
Issue number4
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Cognitive Therapy
Anxiety
Neoplasms
Quality of Life
Therapeutics
Anxiety Disorders
Fear
Comorbidity
Lung Neoplasms
Outcome Assessment (Health Care)
Clinical Trials
Pain
Population

Keywords

  • Anxiety
  • Cancer
  • Cognitive-behavioral therapy
  • Quality of life

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Experimental and Cognitive Psychology
  • Clinical Psychology

Cite this

Tailoring cognitive-behavioral therapy to treat anxiety comorbid with advanced cancer. / Greer, Joseph A.; Park, Elyse R.; Prigerson, Holly G.; Safren, Steven.

In: Journal of Cognitive Psychotherapy, Vol. 24, No. 4, 2010, p. 294-313.

Research output: Contribution to journalArticle

Greer, Joseph A. ; Park, Elyse R. ; Prigerson, Holly G. ; Safren, Steven. / Tailoring cognitive-behavioral therapy to treat anxiety comorbid with advanced cancer. In: Journal of Cognitive Psychotherapy. 2010 ; Vol. 24, No. 4. pp. 294-313.
@article{7d1f0c0bec6e4cfa9a5e8172c1e1ebda,
title = "Tailoring cognitive-behavioral therapy to treat anxiety comorbid with advanced cancer",
abstract = "Patients with advanced cancer often experience debilitating anxiety symptoms that interfere with quality of life and relate to worse medical outcomes. Although cognitive-behavioral therapy (CBT) is an empirically validated, first-line treatment for anxiety disorders, clinical trials of CBT for anxiety typically exclude patients with medical comorbidities in general, and those with terminal illnesses, such as advanced cancer, in particular. Moreover, CBT has generally targeted unrealistic fears and worries in otherwise healthy individuals with clinically significant anxiety symptoms. Consequently, traditional CBT does not sufficiently address the cognitive components of anxiety in patients with cancer, especially negative thought patterns that are rational but nonetheless intrusive and distressing, such as concerns about pain, disability, and death, as well as management of multiple stressors, changes in functional status, and burdensome medical treatments. In this article, we describe a treatment approach for tailoring CBT to the needs of this population. Three case examples of patients diagnosed with terminal lung cancer are presented to demonstrate the treatment methods along with outcome measures for anxiety and quality of life.",
keywords = "Anxiety, Cancer, Cognitive-behavioral therapy, Quality of life",
author = "Greer, {Joseph A.} and Park, {Elyse R.} and Prigerson, {Holly G.} and Steven Safren",
year = "2010",
doi = "10.1891/0889-8391.24.4.294",
language = "English (US)",
volume = "24",
pages = "294--313",
journal = "Journal of Cognitive Psychotherapy: An International Quarterly",
issn = "0889-8391",
publisher = "Springer Publishing Company",
number = "4",

}

TY - JOUR

T1 - Tailoring cognitive-behavioral therapy to treat anxiety comorbid with advanced cancer

AU - Greer, Joseph A.

AU - Park, Elyse R.

AU - Prigerson, Holly G.

AU - Safren, Steven

PY - 2010

Y1 - 2010

N2 - Patients with advanced cancer often experience debilitating anxiety symptoms that interfere with quality of life and relate to worse medical outcomes. Although cognitive-behavioral therapy (CBT) is an empirically validated, first-line treatment for anxiety disorders, clinical trials of CBT for anxiety typically exclude patients with medical comorbidities in general, and those with terminal illnesses, such as advanced cancer, in particular. Moreover, CBT has generally targeted unrealistic fears and worries in otherwise healthy individuals with clinically significant anxiety symptoms. Consequently, traditional CBT does not sufficiently address the cognitive components of anxiety in patients with cancer, especially negative thought patterns that are rational but nonetheless intrusive and distressing, such as concerns about pain, disability, and death, as well as management of multiple stressors, changes in functional status, and burdensome medical treatments. In this article, we describe a treatment approach for tailoring CBT to the needs of this population. Three case examples of patients diagnosed with terminal lung cancer are presented to demonstrate the treatment methods along with outcome measures for anxiety and quality of life.

AB - Patients with advanced cancer often experience debilitating anxiety symptoms that interfere with quality of life and relate to worse medical outcomes. Although cognitive-behavioral therapy (CBT) is an empirically validated, first-line treatment for anxiety disorders, clinical trials of CBT for anxiety typically exclude patients with medical comorbidities in general, and those with terminal illnesses, such as advanced cancer, in particular. Moreover, CBT has generally targeted unrealistic fears and worries in otherwise healthy individuals with clinically significant anxiety symptoms. Consequently, traditional CBT does not sufficiently address the cognitive components of anxiety in patients with cancer, especially negative thought patterns that are rational but nonetheless intrusive and distressing, such as concerns about pain, disability, and death, as well as management of multiple stressors, changes in functional status, and burdensome medical treatments. In this article, we describe a treatment approach for tailoring CBT to the needs of this population. Three case examples of patients diagnosed with terminal lung cancer are presented to demonstrate the treatment methods along with outcome measures for anxiety and quality of life.

KW - Anxiety

KW - Cancer

KW - Cognitive-behavioral therapy

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=77957881376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957881376&partnerID=8YFLogxK

U2 - 10.1891/0889-8391.24.4.294

DO - 10.1891/0889-8391.24.4.294

M3 - Article

VL - 24

SP - 294

EP - 313

JO - Journal of Cognitive Psychotherapy: An International Quarterly

JF - Journal of Cognitive Psychotherapy: An International Quarterly

SN - 0889-8391

IS - 4

ER -